Effects of Climate Change on Areas Suitable for Maize Cultivation and Aflatoxin Contamination in Europe.


Journal

Toxins
ISSN: 2072-6651
Titre abrégé: Toxins (Basel)
Pays: Switzerland
ID NLM: 101530765

Informations de publication

Date de publication:
04 10 2023
Historique:
received: 04 09 2023
revised: 21 09 2023
accepted: 02 10 2023
medline: 30 10 2023
pubmed: 27 10 2023
entrez: 27 10 2023
Statut: epublish

Résumé

The climate is changing in Europe: average temperatures are increasing, and so is the frequency of extreme weather events. Climate change has a severe impact on areas suitable for growing certain crops and on food safety, for example, affecting the occurrence of the aflatoxin contamination of maize. The aim of this study was to obtain insights into the impact of climate change on possible changes in land use in Europe, particularly in areas suitable for maize cultivation, and on the probability of the mycotoxin contamination of maize in order to give directions for long-term adaptation to climate change. By combining a land use model and a mycotoxin prediction model, the suitability of land for maize cultivation and the probability of aflatoxin contamination were estimated for suitable areas in Europe, comparing the current climate with the 2050 scenario. In 2050, the occurrence of aflatoxin contamination in Europe is predicted to severely increase, especially in Central and Southern Europe. More northern regions, presently unsuitable for maize cultivation, will become suitable for maize cultivation in 2050. In the baseline scenario, most regions suitable for maize cultivation have a low probability of aflatoxin contamination, whereas in 2050, about half of the regions suitable for maize cultivation have a medium to high probability of aflatoxin contamination. Regions for safely growing maize for human consumption will shift from the southern to the northern half of Europe.

Identifiants

pubmed: 37888630
pii: toxins15100599
doi: 10.3390/toxins15100599
pmc: PMC10611387
pii:
doi:

Substances chimiques

Aflatoxins 0
Mycotoxins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Food Chem Toxicol. 2009 May;47(5):1009-21
pubmed: 19353812
Front Microbiol. 2021 Apr 13;12:643604
pubmed: 33967981
Toxins (Basel). 2022 Jun 30;14(7):
pubmed: 35878185
Nature. 2010 Feb 11;463(7282):747-56
pubmed: 20148028
Front Vet Sci. 2022 Jan 24;8:822227
pubmed: 35141309
Int J Environ Res Public Health. 2020 Jan 08;17(2):
pubmed: 31936320
PLoS One. 2019 Jun 27;14(6):e0218956
pubmed: 31247003
Toxins (Basel). 2021 Apr 20;13(4):
pubmed: 33924246
Toxins (Basel). 2020 Dec 04;12(12):
pubmed: 33291729
Toxins (Basel). 2021 Apr 12;13(4):
pubmed: 33921529
Toxins (Basel). 2023 Mar 17;15(3):
pubmed: 36977118
Sci Adv. 2021 Feb 3;7(6):
pubmed: 33536204
Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2018 Aug;35(8):1610-1621
pubmed: 29494310
Sci Rep. 2016 Apr 12;6:24328
pubmed: 27066906
Environ Manage. 2002 Sep;30(3):391-405
pubmed: 12148073

Auteurs

Marlous Focker (M)

Wageningen Food Safety Research (WFSR), 6708 WB Wageningen, The Netherlands.

Michiel van Eupen (M)

Wageningen Environmental Research (WEnR), 6708 PB Wageningen, The Netherlands.

Peter Verweij (P)

Wageningen Environmental Research (WEnR), 6708 PB Wageningen, The Netherlands.

Cheng Liu (C)

Wageningen Food Safety Research (WFSR), 6708 WB Wageningen, The Netherlands.

Charlotte van Haren (C)

Wageningen Environmental Research (WEnR), 6708 PB Wageningen, The Netherlands.

H J van der Fels-Klerx (HJ)

Wageningen Food Safety Research (WFSR), 6708 WB Wageningen, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH